{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T15:23:43Z","timestamp":1726759423519},"reference-count":15,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,16]],"date-time":"2013-07-16T00:00:00Z","timestamp":1373932800000},"content-version":"vor","delay-in-days":684,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Value in Health"],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1016\/j.jval.2011.05.002","type":"journal-article","created":{"date-parts":[[2011,6,27]],"date-time":"2011-06-27T18:46:57Z","timestamp":1309200417000},"page":"862-866","source":"Crossref","is-referenced-by-count":10,"title":["Impact of Measures to Enhance the Value of Observational Surveys in Rare Diseases: The Fabry Outcome Survey (FOS)"],"prefix":"10.1016","volume":"14","author":[{"given":"Joe T.R.","family":"Clarke","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Giugliani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gere","family":"Sunder-Plassmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Perry M.","family":"Elliott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guillem","family":"Pintos-Morell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Hernberg-St\u00e5hl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Malmen\u00e4s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Beck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jval.2011.05.002_bib1","first-page":"8","article-title":"Real-life data: a growing need","volume":"13","author":"Annemans","year":"2007","journal-title":"ISPOR CONNECTIONS"},{"key":"10.1016\/j.jval.2011.05.002_bib2","series-title":"Appl Clin Trials","article-title":"When clinical trials aren't enough","author":"Gliklich","year":"2008"},{"key":"10.1016\/j.jval.2011.05.002_bib4","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1136\/bmj.328.7430.39","article-title":"Assessing the quality of research","volume":"328","author":"Glasziou","year":"2004","journal-title":"BMJ"},{"key":"10.1016\/j.jval.2011.05.002_bib5","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1136\/bmj.319.7205.312","article-title":"Methods in health services research","volume":"319","author":"McKee","year":"1999","journal-title":"BMJ"},{"key":"10.1016\/j.jval.2011.05.002_bib6","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1136\/bmj.315.7123.1636","article-title":"Choosing the best research design for each question","volume":"315","author":"Sackett","year":"1997","journal-title":"BMJ"},{"key":"10.1016\/j.jval.2011.05.002_bib7","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/CVM-2-3-109","article-title":"Bridging case-control studies and randomized trials","volume":"2","author":"Rosendaal","year":"2001","journal-title":"Curr Control Trials Cardiovasc Med"},{"key":"10.1016\/j.jval.2011.05.002_bib8","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1365-2362.2004.01309.x","article-title":"Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry Outcome Survey","volume":"34","author":"Mehta","year":"2004","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.jval.2011.05.002_bib9","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1136\/jmg.38.11.769","article-title":"Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 60 obligate carrier females","volume":"38","author":"MacDermot","year":"2001","journal-title":"J Med Genet"},{"key":"10.1016\/j.jval.2011.05.002_bib10","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1023\/A:1012993305223","article-title":"Anderson-Fabry disease: clinical manifestations of disease in female heterozygotes","volume":"24","author":"Whybra","year":"2001","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.jval.2011.05.002_bib11","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1136\/jmg.2005.036327","article-title":"Natural history of Fabry disease in females in the Fabry Outcome Survey","volume":"43","author":"Deegan","year":"2006","journal-title":"J Med Genet"},{"key":"10.1016\/j.jval.2011.05.002_bib12","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1080\/08035250500275022","article-title":"Clinical manifestations of Fabry disease in children: data from the Fabry Outcome Survey","volume":"95","author":"Ramaswami","year":"2006","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.jval.2011.05.002_bib13","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1016\/j.cgh.2007.08.012","article-title":"Gastrointestinal symptoms in 342 patients with Fabry disease: prevalence and response to enzyme replacement therapy","volume":"5","author":"Hoffmann","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jval.2011.05.002_bib14","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1136\/jmg.2005.036327","article-title":"Natural history of Fabry disease in females in the Fabry Outcome Survey","volume":"43","author":"Deegan","year":"2006","journal-title":"J Med Genet"},{"key":"10.1016\/j.jval.2011.05.002_bib15","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1093\/aje\/kwg231","article-title":"Evaluating medication effects outside of clinical trials: new-user designs","volume":"158","author":"Ray","year":"2003","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jval.2011.05.002_bib16","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1016\/S0140-6736(09)61493-8","article-title":"Enzyme replacement therapy with agalsidase alfa in patients with Fabry's disease: an analysis of registry data","volume":"374","author":"Mehta","year":"2009","journal-title":"Lancet"}],"container-title":["Value in Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098301511014185?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098301511014185?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,12]],"date-time":"2019-06-12T08:09:28Z","timestamp":1560326968000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098301511014185"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9]]},"references-count":15,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,9]]}},"alternative-id":["S1098301511014185"],"URL":"https:\/\/doi.org\/10.1016\/j.jval.2011.05.002","relation":{},"ISSN":["1098-3015"],"issn-type":[{"value":"1098-3015","type":"print"}],"subject":[],"published":{"date-parts":[[2011,9]]}}}